Century Therapeutics (IPSC) Change in Acquisitions & Divestments (2020 - 2026)

Century Therapeutics (IPSC) has 7 years of Change in Acquisitions & Divestments data on file, last reported at $28.7 million in Q1 2026.

• On a quarterly basis, Change in Acquisitions & Divestments fell 33.8% year-over-year to $28.7 million in Q1 2026; TTM through Mar 2026 was $144.9 million, a 16.21% decrease from a year earlier, with the FY2025 full-year figure at $159.5 million, down 9.77% from the prior year.
• Change in Acquisitions & Divestments for Q1 2026 stood at $28.7 million, down from $37.8 million in the prior quarter.
• Over the last five years, Change in Acquisitions & Divestments for IPSC reached as high as $110.5 million in Q2 2023 and fell as low as $28.7 million in Q1 2026.
• Historically, Change in Acquisitions & Divestments has averaged $54.1 million across 5 years, with a median of $48.2 million in 2024.
• Across the five-year window, Change in Acquisitions & Divestments soared 719.35% in 2022 and sank 72.97% in 2024, its largest moves.
• Year by year, Change in Acquisitions & Divestments stood at $52.3 million in 2022, then sank by 44.06% to $29.3 million in 2023, then soared by 64.59% to $48.2 million in 2024, then retreated by 21.51% to $37.8 million in 2025, then declined by 24.22% to $28.7 million in 2026.
• Per Business Quant data, the three most recent Change in Acquisitions & Divestments figures were $28.7 million in Q1 2026, $37.8 million in Q4 2025, and $35.9 million in Q3 2025.